NEW YORK (GenomeWeb) – Epigenetics sequencing firm Cambridge Epigenetix today announced the completion of a Series A financing round that raised $5.5 million.

The company also announced the appointment of Fedja Bobanovic as its CEO.

New Science Ventures led the financing, and founding investors Syncona Partners and Cambridge Enterprise participated in the round. Bobanovic said that the funds will be used to continue exploring commercial applications for the firm's products, as well as for R&D.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.